Goo Youn-Kyoung, Xuan Xuenan
National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido 080-8555, Japan. ; Department of Parasitology and Tropical Medicine, Kyungpook National University School of Medicine, Daegu, Korea.
National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido 080-8555, Japan.
Korean J Parasitol. 2014 Aug;52(4):345-53. doi: 10.3347/kjp.2014.52.4.345. Epub 2014 Aug 29.
Babesia gibsoni is an intraerythrocytic apicomplexan parasite that causes piroplasmosis in dogs. B. gibsoni infection is characterized clinically by fever, regenerative anemia, splenomegaly, and sometimes death. Since no vaccine is available, rapid and accurate diagnosis and prompt treatment of infected animals are required to control this disease. Over the past decade, several candidate molecules have been identified using biomolecular techniques in the authors' laboratory for the development of a serodiagnostic method, vaccine, and drug for B. gibsoni. This review article describes newly identified candidate molecules and their applications for diagnosis, vaccine production, and drug development of B. gibsoni.
吉氏巴贝斯虫是一种红细胞内的顶复门寄生虫,可导致犬梨形虫病。吉氏巴贝斯虫感染的临床特征为发热、再生性贫血、脾肿大,有时还会导致死亡。由于尚无可用疫苗,因此需要对感染动物进行快速准确的诊断和及时治疗,以控制这种疾病。在过去十年中,作者所在实验室利用生物分子技术鉴定了几种候选分子,用于开发针对吉氏巴贝斯虫的血清诊断方法、疫苗和药物。这篇综述文章描述了新鉴定的候选分子及其在吉氏巴贝斯虫诊断、疫苗生产和药物开发中的应用。